Week3, 2024
1. Influenza activity remains elevated across most of the U.S. with 14.2% of clinical specimens testing positive for influenza.
2. Out of 699 viruses identified by public health labs, 83.1% were Influenza A and 16.9% Influenza B, with the predominant subtype being A(H1N1)pdm09 (71.4% of subtyped Influenza A viruses).
3. The cumulative hospitalization rate is 43.3 per 100,000, the second-highest for mid-January observed in recent seasons, with 88.4% of hospitalizations linked to Influenza A.
4. Ten pediatric deaths were reported this week, adding to a total of 57 this season, with influenza A(H1N1) contributing to most deaths.
5. Outpatient visits for influenza-like illness accounted for 4.3% of visits, remaining above the national baseline but decreasing from the prior week.
6. Hospital admissions for influenza dropped for the third consecutive week, with 12,382 cases reported during Week 3.
7. Mortality due to influenza accounted for 1.1% of deaths, a decrease compared to the previous week.
8. Regional influenza activity varies, with higher positivity rates in Regions 6, 8, 5, and 3; nationally, positivity trends are stable.
9. Despite current vaccine match to circulating strains, vaccination efforts are still encouraged as influenza viruses continue to spread.
10. Increasing resistance to oseltamivir and peramivir observed in a small subset of A(H1N1)pdm09 viruses emphasizes the need for antiviral monitoring.